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Abstract:  
Background and Aims: Inappropriate drug prescribing has increased especially in developing 
countries where systems for monitoring medicine use are not well developed. This increases the rate 
of antimicrobial resistance. The study aim was to assess the prescribing patterns among urban 
primary health facilities in Botswana to provide future guidance including developing future quality 
indicators. Methods: Retrospective data from patientV¶records between January ± December 2013 in 
19 clinics were collected in a cross-sectional study. The WHO/INRUD indicators were used to assess 
prescribing patterns in the study clinics. Results: Average number of drugs per prescription was 2.8; 
78.6% of the prescribed antibiotics were by INN and 96.1% complied with the Botswana Essential 
Drugs List. Overall rate of antibiotic prescribing was high (42.7%) with 14.7%, 5.9% and 1.3% of 
prescriptions having two, three and four antibiotics respectively. Systemic antibiotics (J01C) were 
most (45.1%) commonly prescribed of which amoxicillin accounted for (28.4%) and metronidazole 
14.4% of all antibiotic prescriptions. There was low use of co-amoxiclav (0.3% of all antibiotic 
prescriptions). Third generation cephalosporins and macrolides accounted for 9.8% and 6.2% of 
antibiotic prescriptions respectively, with no prescribing of fluoroquinolones. The majority of 
indications (87%) for antibiotic prescriptions were according to ICD classification. Conclusions: While 
most indications for antibiotic prescriptions were based on signs and symptoms according to ICD, 
antibiotic prescribing rates were high with some conditions not requiring antibiotics because they are 
viral infections. There is a need to further improve prescribing practices through induction and training 
of in-service prescribers. An effective management tool for monitoring antibiotic prescribing practices 
at PHC facilities should be designed and implemented, including developing robust quality indicators. 
 
:KDW¶Vknown? 
x There is considerable overuse of common antibiotics across countries particularly in primary 
health care centres, leading to increasing resistance rate. 
x There are ongoing developments to improve the use of antibiotics across countries including 
WHO/ INRUD indicators as well as guidelines. 
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x However, there are concerns with the specificity of WHO/INRUD indicators to fully assess the 
quality of antibiotic prescribing in ambulatory care as well as adherence to ICD codes when 
prescribing. 
 
:KDW¶Vnew? 
x There were high rates of INN prescribing in Botswana as well as high rates of prescribing of 
medicines contained in the Botswana EDL. 
x However, there were high rates of antibiotic prescribing as well as high rates of prescribing two or 
more antibiotics on the first encounter. This may be due to a high prevalence of gynaecological 
and sexually transmitted infections in presenting patients in Botswana. 
x The majority of indications for antibiotic prescribing (87%) were in accordance with ICD-10 codes; 
however, rates could be improved to enhance future quality of prescribing. 
 
Key words: Inappropriate drug use, Primary Health Care, prescribing indicators, antibiotics 
prescribing, Botswana 
 
Introduction 
 
The World Health Organization (WHO) defines the rational use of medicines as ³SDWLHQWVUHFHLYH
medications appropriate to their clinical needs, in doses that meet their own individual requirements 
for an adequate period of time, at the lowest cost to them DQGWKHLUFRPPXQLW\´ [1]. To address the 
irrational use of medicines, including inappropriate use of antibiotics leading to increasing rates of 
antimicrobial resistance (AMR) with its associated impact on morbidity, mortality and costs [2-8], the 
WHO in collaboration with the International Network for Rational Use of Drugs (INRUD) have 
developed core indicators for prescribing practices, patient care and facility specific factors [2,9,10]. 
These include the number of antibiotics per prescription without looking at issues of necessity or 
whether prescribing adheres to current guidelines [11]. The current World Health Organisation 
reference value for the average number of medicines per encounter is <2 [10,12,13], with a 
comprehensive review between 1990 and 2009 reporting the average number among 104 countries 
was 2.6 for the Africa region [14]. More recent reports indicate a 45.8% increase from 2.4 between 
1995 ± 2005 to 3.5 between 2006 and 2015 [10]. The percentage of medicines prescribed by the 
generic (International Non-proprietary Name; INN) name should be 100% (acceptable >80%) [2,9,13]. 
However, studies have reported lower rates for the African region at between 60% to 68% [5,12].  
 
Currently, there is a scarcity of data regarding the quality of antibiotic prescribing in developing 
countries. In these settings, it is common for antibiotics to be prescribed for typically self-limiting 
conditions such as acute upper respiratory tract infections (URTIs) that are predominantly viral in 
origin and for other infections which do not require antibiotics [4,15-19]. This situation is worse in 
African countries. The comparative report of antibiotic prescribing rates in the Africa region between 
1995 ± 2005 and 2006 ± 2015 shows during the later period high antibiotic prescribing rates (22%, 
58% and 22%) in Ghana, Tanzania and Nigeria respectively [20-22], with most of the increase due to 
prescribing in URTIs which are typically viral in origin.  Overall, approximately 50% of current antibiotic 
prescribing in outpatient departments is seen as inappropriate [23]. In Malaysia, as in Botswana, 
antibiotics are commonly and inappropriately prescribed by primary health care providers at Primary 
Health Care (PHC) facilities [24-27]. Most of these reports though are based on small-scale studies, 
which could be underestimation of the extent of antibiotic use in developing countries.  
 
 
Following the Alma Ata Declaration in 1978 [28], Botswana developed a successful and 
comprehensive primary health care (PHC) system with treatment provided in accordance with the 
standards set out in the Ministry of Health guidelines [29]. However to date, few studies have been 
undertaken to assess prescribing practices in PHC facilities in Botswana [30-32]. We have previously 
reported that 52 different documents/guidelines existed at 18 PHC facilities in the Greater Gaborone 
area of Botswana, of which 50% focused on treatment and management of diseases, the remaining 
50% were general information and policy related [33]. Except for the guidelines for treating STIs found 
at 86% of the facilities, the majority of PHC facilities (56%) did not have current guidelines and the 
Botswana Treatment Guide was only found at 50% of the clinics [33].   
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Aims 
 
The aim of this study was to assess current drug prescribing practices in PHC facilities in Gaborone 
and surrounding areas with a specific emphasis on antibiotic prescribing.  The study results would be 
used to guide future corrective interventions. The interventions may include suggestions to develop 
new quality indicators, especially for antibiotic prescribing, in ambulatory care given the rather crude 
nature of current WHO/ INRUD indicators [9,10]. 
 
Methodology 
 
This was a non-experimental cross-sectional descriptive study initially using the WHO/INRUD 
indicators [9] before looking more specifically at antibiotic prescribing. The study was carried out 
between November ± December 2015, collecting retrospective data from patient records for the 
period between January and December 2013. The PHC facilities were from Gaborone District, 
Tlokweng (South East District) and Mogoditshane (Kweneng District). The facilities are representative 
of urban settings in Botswana where the majority of patients seek their treatment from. 
 
Sample size and sampling procedures 
The WHO [9] recommends that there should be a minimum of 600 prescribing episodes included in a 
cross-sectional indicators survey, and where there are fewer than 20 facilities in a geographical or 
administrative region to be studied, all facilities should be included in the sample. The selected 
districts have a total of 20 PHC facilities; all were included in the study.  
 
Data was collected by trained research assistants under the supervision of the principal researchers 
(YM and ES). 8VLQJSDWLHQW¶VUHFRUGVZe estimated to collect at least 30 prescriptions from each 
PHC. To achieve this, patient prescription records were listed according to the month in which they 
were prescribed and assigned random numbers. Records were then randomly selected until a sample 
size of 30 patient records was realized. We wanted to assess initial prescriptions only in this study. 
Consequently, all records that showed re- attendances were excluded from the study. The diagnoses 
on the patient¶VUHFRUGV were used to determine the indication for antibiotic prescription without 
contact with the prescriber. 
 
Quality of antibiotic prescribing 
The quality of antibiotic prescribing practices were assessed as follows: (a) prescribing against WHO/ 
INRUD criteria [9,10,13]; (b) antibiotic prescribing against indicators developed and proposed by 
European organisations and (c) antibiotic prescribing against the Botswana Essential Drug List [34].  
 
The following indicators have been proposed and used by European organisations to assess the 
quality of systemic antibiotic (J01) prescribing [35-37]:  
x Utilisation of penicillin (J01C) as a % of total antibiotic use 
x Utilisation of combination penicillin (e.g. co-amoxiclav) as a % of total amoxicillin use 
x Utilisation of third- and fourth-generation cephalosporins versus first- and second- generation 
cephalosporins 
x Utilisation of fluoroquinolones (J01MA) as a % of total antibiotic use 
 
Prescribing rates at PHC facilities in Botswana were assessed against published rates among low 
and middle income European countries, including former Soviet Union Republics, as no baseline data 
currently exists for these facilities in Botswana [37,38]. 
 
The utilisation metric used is a prescription rather than internationally recognised metrics such as 
defined daily doses (DDDs) or DDDs per one thousand inhabitants per day (DIDs) [37-39]. This is 
because we wanted to assess antibiotic prescribing for the first indication, and we were evaluating 
antibiotic prescribing among providers at PHC facilities rather than the population as a whole.  
 
Data processing and analysis 
For the purpose of improving the quality of data and the rigor of research results, data management 
procedures and processes were in accordance with the methodology proposed by Vittinghoff et al. 
[40].  This included data preparation, cleaning, editing, and creation of variables and identification of 
missing data. Since we were not testing any outcome variables against exposure interventions, and 
we were not assessing associations between the prescribers and prescribed drugs, only descriptive 
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and inferential analysis frameworks were used to analyse prescribing information.  Percentages, 
averages and frequencies were also used to describe the data.  
 
Ethical considerations  
The study received ethical clearance from the University of Botswana, Institutional Review Board 
(Ref. URB/IRB/1506) and a permit to carry out the study in the PHC facilities was obtained from the 
Ministry of Health and Wellness (Ref. PME.13/18/87). The District Health Management Team 
Coordinator granted access to the facilities vide letter Ref: GGDHMT/14/2/i dated 28th November 
2014. The identity of the clinics were protected by keeping them anonymous and assigned coded 
numbers.  
 
Results 
 
General  
Data from 19 PHC facilities only were analysed. Data from one clinic was not collected because 
during data collection, the clinic staff were on vacation. Out of an estimated 570 prescriptions that 
were collected, 20 prescriptions were excluded from the final analysis because seven patients had 
come to the clinics for routine Antenatal Clinic, six were patients who had visited the clinics for 
counselling services and another seven visited the facilities for HIV testing. This report is therefore 
based on 550 prescriptions.  
 
Prescribing practices against documented indicators 
The total number of prescriptions analysed were 550 and the total number of medicines prescribed for 
all conditions were 1551, giving an average of 2.8 drugs per prescription. Of the total medicines 
prescribed, 1219 (78.6%) were prescribed using International Non-proprietary Names (INN) and 235 
(42.7%) encounters contained at least one antibiotic prescription. 1490 (96.1%) were prescribed from 
the Botswana Essential Drug (EDL) (Table 1). 
 
Table 1: Prescribing practices against documented indicators 
 
 
Prescriptions with antibiotics 
Table 2 shows that 306 antibiotics were prescribed during 235 patient encounters, of which 17 were 
topical applications (13 Chloramphenicol ointments, 3 Tetracycline ointments and one gentamicin 
ointment prescription). Systemic antibiotics (J01) were the most commonly prescribed. The beta-
lactam antibiotics (J01C) accounted for 45.4% of prescriptions, rising to 48.1% when only systemic 
antibiotics were considered. Amoxicillin was the most commonly prescribed antibiotic (28.4%) 
followed by metronidazole (14.4%). Co-amoxiclav accounted for only 0.3% of all antibiotic 
prescriptions, while cotrimoxazole (sulphamethoxazole + tromethropim) accounted for 9.2% of all 
antibiotic prescriptions. Third generation cephalosporin (ceftriaxone) and macrolides (erythromycin) 
accounted for 9.8% and 6.2% of antibiotic prescriptions respectively. This increased to 10.4% and 
6.6% respectively when only J01 systemic antibiotics were considered. No fluoroquinolones (J01MA) 
were prescribed. 
 
  
   
Prescription practices N % 
Total number of prescriptions analysed 550  
Total number of drugs prescribed 1551  
Average drugs/prescription 2.8  
Total prescriptions with generic (INN) names 1219 78.6 
Total antibiotic encounters 235 42.7 
Medicines from EDL 1490 96.1 
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Table 2: Commonly prescribed antibiotics at PHC facilities in Botswana 
 
Antibiotic ATC classification Frequency (N) Per cent 
Beta-lactams (J01C)    
Amoxicillin J01CA04 87 28.4 
Ampicillin J01CA01 3 1.0 
Benzathine Penicillin (Retarpen) J01CE08 13 4.2 
Cloxacillin J01CF02 21 6.9 
Co-amoxiclav J01CR02 1 0.3 
Crystalline Penicillin J01CE01 1 0.3 
Penicillin V J01CE02 13 4.2 
Total Beta-lactams  139 45.4% 
Cotrimoxazole J01EE01 28 9.2 
Ceftriaxone J01DD54 30 9.8 
Chloramphenicol capsules S01A01 3 1.0 
Chloramphenicol ointment S01AA01 13 4.2 
Doxycycline J01AA02 23 7.5 
Erythromycin J01FA01 19 6.2 
Gentamicin J01GB03 2 0.7 
Metronidazole J01XD01 44 14.4 
Nitrofurantoin (Nitrofuran derivative) J01XE 1 0.3 
Tetracycline ointment S01AA 3 1.0 
Gentamicin ointment SO1AA 1 0.3 
Total 
 
306 100 
 
Indications for antibiotic prescriptions 
Table 3 shows 69 diagnoses for which antibiotic prescriptions were written. Most diagnoses were 
based on signs and symptoms whilst some were specific disease conditions including asthma, 
diabetes, bronchitis, tonsillitis, conjunctivitis, chicken pox.  
 
The majority of the antibiotic prescriptions (60) were compliant with the International Classification of 
Diseases (2017 ICD) while nine were not. The nine prescriptions were non-specific, unconventional 
and lacked crucial information such as sputum information on the amount, colour, odour, and the 
presence of blood; µenlarged stomach¶ did not specify whether the enlargement was due to gas, solid 
mass, shifting or fluctuating; µlocal sepsis¶ did not contain information on location and nature of sepsis 
and for bacterial exudate the nature of the exudate (clear fluid, puss, odour) was not provided. Painful 
armpit lacked information on the nature of pain (throbbing, piercing, dull) and with or without 
induration.  
 
Table 3: Classification of the diseases, symptoms and signs indicated for antibiotics prescription at 
PHC facilities in Botswana by 2017 ICD10-CM/Code. 
 
Condition ICD-10-CM/ Code Frequency 
General symptoms and signs 
Fever R50 10 
Headache R51 8 
Dehydration E86.0 1 
Symptoms & signs involving the circulatory and respiratory systems 
Cough R05 37 
Acute tonsillitis J03 18 
6 
 
Nasal congestion (Common cold) J00 7 
Pharyngitis J02 4 
Sputum (unspecified) R09.3 3 
Swollen palate (Acute laryngitis & 
tracheitis) J04 2 
Asthma J45.909 2 
Pleural thickening L85.9 2 
Upper respiratory infections J06 2 
Aspiration pneumonia J69.0 1 
Bronchitis J20.0 1 
Symptoms & signs involving the digestive system & abdomen 
Diarrhoea R19 15 
Abdominal & pelvic pain R10 11 
Loss of appetite R63 6 
Nausea & vomiting R11 4 
Constipation K59.0 1 
Enteritis K52.9 1 
Heartburn (epigastric pain) R12 1 
Symptoms & signs involving the skin & subcutaneous tissues 
Wound/sores T81.30 12 
Rash CM/21 9 
Boils & abscesses CM/22 8 
Skin condition unspecified R23 7 
Herpes zoster B02 2 
Chickenpox B01 2 
Burn T30.0 2 
Allergic dermatitis (Unspecified) L23.89 2 
Acne CM/706 1 
Fibrobullar M72 1 
Viral warts (genital) B07 1 
Implantation (sub-dermal 
contraceptive) V25.5 1 
Skin fungal infection (unspecified) L08.9 1 
Endocrine, nutritional and metabolic disease 
Diabetes mellitus E08 1 
Symptoms & signs involving genitourinary system 
Vaginal discharge (unspecified) N89.8 34 
Sexually transmitted infections 
(Unspecified) A64 25 
Dysuria (Unspecified) R30.0 6 
Penile discharge (Unspecified) R36.9 5 
Pelvic Inflammatory Disease (PID) N73.9 4 
Vagina itching (Unspecified) N89.4 3 
Menstrual Disorder Syndrome N92.6 3 
Ovarian cyst N83.2 3 
Pregnancy masses CM/09A 3 
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Orchitis N45.2 2 
Post Safe Male Circumcision (SMC) Z41.2 2 
Painful urinary bladder (unspecified) N32.9 1 
Diseases of the ear and mastoid process 
Otitis media H60 7 
Painful jaw   2 
Disorders of soft tissues and chest 
Chest pain (unspecified) R07.9 10 
Backache M54.9 2 
Joint pain M79.609 1 
Diseases of the eye and adnexa 
Conjunctivitis H10.0 5 
Dacryocystitis (unspecified) H04.309 1 
Symptoms and signs involving breast 
Swollen breast (engorged) N64.59 1 
Dental and oral diseases 
Dental caries (Unspecified) K02.9 3 
Chronic Periodontitis K05.3 2 
Toothache (Unspecified) K08.8 1 
Traumatic disorders 
Injury (unspecified) CM/929.9 14 
Fractured index finger (unspecified) S62.600A 1 
Other unspecified symptoms and 
signs     
Altered discomfort   1 
Swollen fore skin   1 
Enlarged stomach   1 
Swellings (unspecified)   4 
Local sepsis   2 
Bacterial exudate   1 
Itchy eyes   8 
Painful armpit   1 
Muscle pain (unspecified)   1 
 
Cough, vaginal discharge and sexually transmitted infections were most commonly indicated for 
antibiotic prescriptions in that order. For symptoms and signs involving the gastrointestinal system, 
diarrhoea was the commonest indication for antibiotic. 
 
Indications for more than one antibiotic per prescription    
Out of the 235 encounters with antibiotic prescriptions, 45 (19.1%), 18 (7.7%) and 4 (1.7%) had two, 
three and four antibiotics per prescription respectively . Doxycycline was the most common antibiotic 
combined as a second line drug followed by metronidazole and ceftriaxone respectively (Table 4). 
The indications for combination of antibiotics were mostly sexually transmitted conditions including 
vaginal and urethral discharge and pelvic inflammatory diseases.  
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Table 4: The pattern of antibiotic combinations and the indications at PHC facilities in Gaborone, 
South East and Kweneng districts, Botswana. 
 
Antibiotics Diagnoses 
Amoxicillin Metronidazole     Cough Chest pain 
Amoxicillin Gentamicin ear 
drops 
    Ear sores   
Amoxicillin Metronidazole     Agsoris Headache 
Amoxicillin Metronidazole Retarpen   Pharyngitis Swollen jaw 
Amoxicillin Cotrimoxazole     Post SMC    
Amoxicillin Cotrimoxazole     Cough Eye watering 
Amoxicillin Metronidazole     Abscess   
Amoxicillin Ceftriaxone     PV discharge   
Amoxicillin Metronidazole     Dental caries   
Augmentin Doxycycline     Pelvic pain Pleural thickening 
Benzathine 
Penicillin 
Doxycycline Metronidazone Ceftriaxone PV discharge    
Benzathine 
Penicillin 
Ceftriaxone     Gonococcal 
infection 
  
Benzathine 
Penicillin 
Penicillin V     Tonsillitis   
Benzathine 
Penicillin 
Amoxicillin     Sputum   
Benzathine 
Penicillin 
Amoxicillin     NIL   
Benzathine 
Penicillin 
Amoxicillin     Bacterial 
exudate 
  
Ceftriaxone Metronidazole Doxycycline   PV discharge   
Ceftriaxone Doxycycline Metronidazole   PV discharge   
Ceftriaxone Doxycycline Metronidazole   PV discharge   
Ceftriaxone Doxycycline Metronidazole   Penile rash   
Ceftriaxone Metronidazole     Abdominal 
pain 
  
Ceftriaxone Doxycycline     Urethral 
discharge 
  
Ceftriaxone Doxycycline Metronidazole   Pelvic pain PV discharge 
Ceftriaxone Doxycycline Metronidazole   PV discharge   
Ceftriaxone Doxycycline Metronidazole   STI discharge   
Ceftriaxone Erythromycin     PV discharge Gynaecological 
pelvis 
Ceftriaxone Doxycycline Metronidazole   PV discharge VRT 
Ceftriaxone Cotrimoxazole Metronidazole Doxycycline PV discharge   
Ceftriaxone Metronidazole Erythromycin   Pregnant 
masses 
  
Ceftriaxone Erythromycin Metronidazole Cotrimoxazole PV discharge Dysuria 
Ceftriaxone Doxycycline     Urethral 
discharge 
  
Cloxacillin Bactrim     Abscess   
Cotrimoxazole Ceftriaxone Doxycycline Metronidazole PID   
Doxycycline Ceftriaxone     Orchitis   
Doxycycline Metronidazole     STI contact   
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Doxycycline Metronidazole     STI contact   
Doxycycline Ceftriaxone Metronidazole   PV discharge   
Gentamicin Chloramphenicol     Dacryocystitis Chest pain 
Metronidazole Ceftriaxone Erythromycin   PV discharge   
Metronidazole Ceftriaxone Doxycycline   PV discharge   
Metronidazole Cotrimoxazole     Abscess Scapular wound 
& cold 
Metronidazole Doxycycline Ceftriaxone   Pelvic pain Ovarian cyst 
Metronidazole Doxycycline     MDS PV discharge 
Metronidazole Erythromycin     Genital warts Cough 
Penicillin V Cotrimoxazole     Tonsillitis   
 Frequency 45 18 4 
  
NB: MDS = Menstrual Disorder Syndrome; PID = Pelvic Inflammatory Disease; SMC = Safe Male 
Circumcision; Cold = common cold. 
 
Discussion  
 
When treatments were assessed against crude WHO/ INRUD indicators, there was evidence of good 
prescribing practices in Botswana. This is shown by the fact that 96% of medicines prescribed were in 
accordance with the Botswana EDL and 79% of prescribing was by INN name (Table 2). The high 
rate of prescribing in accordance with the Botswana EDL [34] compares favourably with WHO 
recommendations of 100% [10,12,13,41] as well as rates of 55% to 80% reported for the Africa, 
Europe, Americas and South East Asia regions [2,10,42]. The high prescribing rate from the EDL 
could be attributed to easy accessibility of the Botswana Treatment Guidelines at PHC facilities [33], 
the routine availability of medicines incorporated into the Botswana EDL in PHCs, and the limited 
influence of pharmaceutical companies unlike other countries [2,21,43-46]. 
 
The high rate of INN prescribing in this study is comparable to 78% in the Western Pacific region but 
higher than rates of 27.7% and 48.9% reported in the Eastern Mediterranean and Southeast Asian 
regions [41] as well as 68% for Africa as a whole [10]. Possible explanations for high INN prescribing 
in this study could be a result of frequent in-service training workshops for health workers in Botswana 
sponsored by the government, benchmarking with colleagues in the region, the establishment of a 
medical school whose trainees are exposed to patient care early in their training where prescribing is 
typically INN, and easy access to digital information. This mirrors successful campaigns in other 
countries such as the UK with its high rate of INN prescribing [47,48]. In order to attain WHO 
recommendation [9,10], we believe INN prescribing training should be intensified through regular 
training of in-service practitioners. 
 
In this study, 42.7% of the encounters contained an antibiotic prescription, higher than < 30% 
recommended by WHO [10,12,13]. This is marginally higher than 39% and 34% for the Americas and 
European regions, but lower than 53% for the Eastern Mediterranean region [41] and Africa as a 
whole (47%) [10]. This rate is also higher than 27% in a previous study in Botswana [31], and higher 
than 30% for Acute Respiratory Infections in children under 5 years old previously reported in 
Botswana [32]. The high use of antibiotics could be due to a high burden of gynaecological and 
sexually transmitted infections (Table 3). There is also high prevalence (pandemic) of HIV in 
Botswana [49]. However, these patients are normally treated in specialist clinics, although in some 
cases, opportunistic infections may be treated in PHCs. The extent of multiple antibiotic prescribing is 
a concern, but again may reflect the high prevalence of gynaecological and sexually transmitted 
infections in our study with up to three antibiotics recommended in the Botswana guidelines for these 
patients (Table 4). This will be a future area of research. 
 
Regarding the quality of antibiotic prescribing, it is generally accepted as good clinical practice that 
antibiotics should be prescribed for specific diagnosis. We found that most of the indications for 
antibiotic prescriptions were based on signs and symptoms, rather than specific diagnoses, and were 
compliant with ICD (Table 3). However, nine conditions did not match the ICD which could either 
result from failure of patients to express themselves during history taking, poor history taking or the 
inability of prescribers to apply ICD codes when arriving at differential and definitive diagnoses. 
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Adoption of ICD 10 codes for primary care diagnoses would go a long way towards creating a 
common language for classifying undifferentiated conditions that are seen in primary health care 
settings. 
 
There are concerns that some diagnoses such as a common cold, diarrhoea, painful legs, 
constipation, and unclassified muscular pains, do not warrant antibiotics (Table 3). In addition, four 
prescriptions each containing antibiotics had no established diagnosis. The situation in this study is 
however better than reported LQ1LJHULDZKHUHRYHURIWKHSDWLHQW¶VIROGHUVUHYLHZHGKDGQR
established diagnosis [50].  The factors that contribute to over prescribing of antibiotics include 
inadequate in-service training, socio-cultural factors and patient demand [16,18,27,51].   Most health 
facilities in Botswana and elsewhere are characterised by inadequate skilled human resources. These 
lower level healthcare workers are overwhelmed by the large number of patients seeking care and 
some pressurising on prescribers to prescribe injections and antibiotics [52-54]. The establishment of 
the Medical School in 2009 is a dedicated effort by the Government of Botswana to improve the 
number and quality of health care providers in the country. Assessment of factors influencing 
antibiotic prescribing practices was outside the scope of this study but will be explored further in future 
research. 
 
The high use of beta-lactamase antibiotics compares favourably with former Soviet Union Republics 
and Turkey with rates of 37.5% to 65.6% of total J01 antibiotics [37]. The low use of  co-amoxiclav is 
also encouraging as there are concerns that high utilisation increases side-effects and resistance as 
well as costs [55-57]. With rising concerns on the development of C.difficle resistance [58,59], the low 
utilisation of cephalosporins in this study (Table 2) is also encouraging and compares favourably with 
rates of 0.5% to 12.2% among former Soviet Union Republics and Turkey [37]. Similarly, the lack of 
fluoroquinolone prescribing is encouraging, helped by the lack of inclusion of the drugs in the 
Botswana EDL [34]. 
 
In our future research, we will aim to explore adherence to treatment guidelines alongside 
establishing quality indicators for antibiotic prescribing among providers in both urban and rural PHC 
facilities in Botswana, which will assist prescribers with improving their quality of care [60]. Adherence 
is a complex phenomenon and typically far from optimal across countries [19,61-63]. For instance, 
46% of antibiotic prescriptions in a recent study were not indicated by the guidelines [64]. However, 
higher adherence rates were recently seen in Namibia (62%), although below national target rates of 
95% [11]. Guideline adherence is influenced by several factors including the level of training of PHC 
personnel, available resources at health care facilities, workload, staff motivation, staff experience, 
and the availability of managerial tools for monitoring prescribing patterns. Physicians may also 
misinterpret patient expectations, influencing adherence rates [65]. Effective monitoring can enhance 
adherence rates [66]. Care though must be taken in communicating appropriate guidelines, especially 
if there are differences between different policies and guidelines as recently seen in Namibia [67]. 
 
Based on our findings, we recommended that in order to improve prescribing at PHC facilities in 
Botswana, it is essential that prescribers be provided with in-service training on the use of current 
national treatment guidelines, classification of diseases, INN prescribing, as well as proper history 
taking and recording of diagnoses. In addition, Botswana should consider adopting ICD 10 for primary 
care to aid easier classification of undifferentiated conditions that present in PHC facilities. 
Pharmacists should also play a key role in promoting rational prescribing practices by conducting drug 
utilisation reviews and using the findings to stimulate dialogue among practitioners to enhance the 
future rational use of medicines at PHC facilities.  
 
The Ministry of Health and Wellness, as the major stakeholder responsible for policy formulation and 
guidance, should seek to design a harmonised managerial tool that will contain pertinent quality 
indicators for monitoring antibiotic prescribing practices at all PHC facilities. This includes targets for 
adherence to National Treatment Guidelines as well as classes of antibiotics prescribed, building on 
European and other guidance. Any quality indicators developed must reflect current conditions in 
ambulatory care as seen by the high prevalence of gynaecological and sexually transmitted infections 
in Botswana, which is not universal especially among European populations. This will help address 
concerns with current WHO/ INRUD criteria. Similarly, multi-sector antimicrobial initiatives and 
programmes should be developed and implemented across all locations to improve future antibiotic 
prescribing through monitoring antimicrobial usage as well as developing and implementing strategic 
interventions aimed at optimising antimicrobial use and reducing AMR. This may help to improve 
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antibiotic prescribing in the future in Botswana and reduce AMR rates. Hopefully any quality indicators 
developed will also be of interest to other African countries and wider with similar populations. 
 
Limitations 
The study was carried out in an urban area of Botswana and did not include rural areas. However, as 
mentioned, this is where the majority of patients are currently treated in Botswana, although we 
recognise there could be differences in the characteristics of the respective patient populations. In 
addition, the results are from a retrospective collection of data, and information on the characteristics 
of practitioners was not collected. However, we believe our findings will already give guidance to key 
stakeholders on ways to improve antibiotic prescribing in Botswana. We also believe our on-going 
research to develop pertinent quality indicators across all locations, including both urban and rural 
PHCs, will be of interest to other African countries and wider. 
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